Ibrexafungerp: Mechanism of Action, Clinical, and Translational Science
ABSTRACT Ibrexafungerp is a first‐in‐class triterpenoid antifungal that targets β‐(1,3)‐glucan synthase in fungal cell wall development. It is indicated for vulvovaginal candidiasis (VVC) and recurrent vulvovaginal candidiasis (RVVC) in adult and post‐menarchal pediatric females. The drug was approv...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wiley
2025-09-01
|
| coleção: | Clinical and Translational Science |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1111/cts.70362 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|